| Year |
Citation |
Score |
| 2018 |
Magbanua M, Hendrix L, Hyslop T, Barry W, Winer E, Hudis C, Toppmeyer D, Burnstein H, Qadir M, Ma C, Scott J, Park J, Rugo H. Abstract P2-01-01: Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-01-01 |
0.39 |
|
| 2017 |
Magbanua M, Hauranieh L, Roy R, Wolf D, Benz S, Vaske C, Pendyala P, Sosa E, Scott J, Lee J, Ordonez A, Ho B, Solanki T, VantVeer L, Rugo H, et al. Abstract P1-01-04: Comprehensive genomic characterization of circulating tumor cells (CTCs) in metastatic breast cancer (MBC) sheds light on the biology of blood-borne metastasis Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-01-04 |
0.381 |
|
| 2016 |
Lee JS, Magbanua MJ, Park JW. Circulating tumor cells in breast cancer: applications in personalized medicine. Breast Cancer Research and Treatment. PMID 27761678 DOI: 10.1007/s10549-016-4014-6 |
0.305 |
|
| 2015 |
Magbanua MJ, Wolf DM, Yau C, Davis SE, Crothers J, Au A, Haqq CM, Livasy C, Rugo HS, Esserman L, Park JW, van 't Veer LJ. Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response. Breast Cancer Research : Bcr. 17: 73. PMID 26021444 DOI: 10.1186/s13058-015-0582-3 |
0.623 |
|
| 2015 |
Magbanua MJ, Carey LA, DeLuca A, Hwang J, Scott JH, Rimawi MF, Mayer EL, Marcom PK, Liu MC, Esteva FJ, Park JW, Rugo HS. Circulating tumor cell analysis in metastatic triple-negative breast cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1098-105. PMID 25524311 DOI: 10.1158/1078-0432.CCR-14-1948 |
0.303 |
|
| 2015 |
Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua MJ, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW. Expression profiling of circulating tumor cells in metastatic breast cancer. Breast Cancer Research and Treatment. 149: 121-31. PMID 25432738 DOI: 10.1007/s10549-014-3215-0 |
0.63 |
|
| 2014 |
Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, Rubashkin MG, Magbanua MJ, Thorn KS, Davidson MW, Rugo HS, et al. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 511: 319-25. PMID 25030168 DOI: 10.1038/Nature13535 |
0.331 |
|
| 2014 |
Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes & Control : Ccc. 25: 515-23. PMID 24504435 DOI: 10.1007/s10552-014-0354-x |
0.657 |
|
| 2014 |
Magbanua MJ, Melisko M, Park J. Molecular characterization of cerebrospinal fluid tumor cells associated with leptomeningeal carcinomatosis Cancer Cell & Microenvironment. 1. DOI: 10.14800/Ccm.167 |
0.402 |
|
| 2013 |
Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJ, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. The Lancet. Oncology. 14: 1112-20. PMID 24051140 DOI: 10.1016/S1470-2045(13)70366-8 |
0.306 |
|
| 2013 |
Magbanua MJ, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Research. 73: 30-40. PMID 23135909 DOI: 10.1158/0008-5472.CAN-11-3017 |
0.306 |
|
| 2012 |
Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, Ryan CJ, Park JW. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. Bmc Cancer. 12: 78. PMID 22373240 DOI: 10.1186/1471-2407-12-78 |
0.398 |
|
| 2011 |
Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. Plos One. 6: e24004. PMID 21912659 DOI: 10.1371/journal.pone.0024004 |
0.669 |
|
| 2011 |
Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes & Control : Ccc. 22: 141-50. PMID 21103921 DOI: 10.1007/s10552-010-9684-5 |
0.665 |
|
| 2011 |
Magbanua M, Hauranieh L, Pendyala P, Sosa E, Scott J, Rugo H, Park J. P4-07-17: Isolation of Highly Pure Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients for Gene Expression Analysis. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-07-17 |
0.465 |
|
| 2009 |
Lang JE, Magbanua MJ, Scott JH, Makrigiorgos GM, Wang G, Federman S, Esserman LJ, Park JW, Haqq CM. A comparison of RNA amplification techniques at sub-nanogram input concentration. Bmc Genomics. 10: 326. PMID 19619282 DOI: 10.1186/1471-2164-10-326 |
0.566 |
|
| 2008 |
Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proceedings of the National Academy of Sciences of the United States of America. 105: 8369-74. PMID 18559852 DOI: 10.1073/pnas.0803080105 |
0.64 |
|
| Show low-probability matches. |